Total Payments
$3,738
2024 Payments
$813.80
Companies
16
Transactions
74
Medicare Patients
1,997
Medicare Billing
$269,752
Payment Breakdown by Category
Food & Beverage$3,738 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,738 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,622 | 20 | $0 (2024) |
| EISAI INC. | $488.51 | 12 | $0 (2019) |
| Medtronic USA, Inc. | $339.09 | 4 | $0 (2018) |
| Jazz Pharmaceuticals Inc. | $271.87 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $209.65 | 12 | $0 (2018) |
| Abbott Laboratories | $204.84 | 4 | $0 (2022) |
| Neurelis, Inc. | $183.84 | 3 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $142.01 | 2 | $0 (2021) |
| ABBVIE INC. | $88.16 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $78.12 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $813.80 | 9 | UCB, Inc. ($749.15) |
| 2023 | $969.19 | 10 | UCB, Inc. ($504.05) |
| 2022 | $253.84 | 6 | Abbott Laboratories ($162.50) |
| 2021 | $77.94 | 5 | Abbott Laboratories ($42.34) |
| 2020 | $98.24 | 5 | UCB, Inc. ($41.64) |
| 2019 | $540.19 | 12 | EISAI INC. ($356.86) |
| 2018 | $689.68 | 19 | Medtronic USA, Inc. ($237.27) |
| 2017 | $295.56 | 8 | UCB, Inc. ($122.14) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Neurelis, Inc. | — | Food and Beverage | In-kind items and services | $45.68 | General |
| 09/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: Neurology | ||||||
| 09/11/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $107.33 | General |
| 08/05/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 05/21/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $72.61 | General |
| 05/03/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $62.15 | General |
| 02/08/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $132.27 | General |
| Category: Neurology | ||||||
| 11/01/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: EPILEPSY | ||||||
| 09/27/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $127.84 | General |
| 09/20/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/22/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $126.42 | General |
| 05/25/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: NEUROLOGY | ||||||
| 04/18/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 03/02/2023 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Neurology | ||||||
| 01/30/2023 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Neuroscience | ||||||
| 09/09/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.96 | General |
| Category: Neuroscience | ||||||
| 07/31/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Neuroscience | ||||||
| 06/26/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Neuroscience | ||||||
| 06/04/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Neuroscience | ||||||
| 04/29/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Rare Disease | ||||||
| 03/28/2022 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $162.50 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 397 | 432 | $228,942 | $41,399 |
| 2022 | 9 | 407 | 518 | $294,519 | $53,672 |
| 2021 | 13 | 583 | 772 | $468,110 | $90,512 |
| 2020 | 16 | 610 | 755 | $417,048 | $84,168 |
Total Patients
1,997
Total Services
2,477
Medicare Billing
$269,752
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 100 | 102 | $60,792 | $11,556 | 19.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 70 | $60,923 | $10,476 | 17.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 60 | $26,940 | $6,166 | 22.9% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 15 | 19 | $17,784 | $3,295 | 18.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 48 | $14,976 | $3,280 | 21.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 66 | 68 | $20,726 | $3,105 | 15.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 44 | 45 | $17,741 | $2,039 | 11.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 20 | 20 | $9,060 | $1,482 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 178 | $100,036 | $16,896 | 16.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 53 | $46,133 | $9,089 | 19.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 95 | $42,621 | $8,337 | 19.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 56 | $33,406 | $6,220 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $27,740 | $5,095 | 18.4% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $15,855 | $3,020 | 19.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $11,955 | $2,302 | 19.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 28 | 28 | $8,555 | $1,359 | 15.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 28 | 28 | $8,218 | $1,354 | 16.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 128 | 215 | $117,694 | $22,354 | 19.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 88 | 90 | $78,783 | $15,861 | 20.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 64 | 119 | $53,364 | $10,790 | 20.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 29 | 29 | $45,841 | $9,227 | 20.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $34,607 | $6,157 | 17.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 36 | 37 | $29,533 | $5,910 | 20.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 51 | 82 | $25,584 | $5,185 | 20.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 17 | 25 | $30,641 | $4,868 | 15.9% |
About Dr. Dalia Lorenzo, MD
Dr. Dalia Lorenzo, MD is a Neurology healthcare provider based in Medley, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760402820.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dalia Lorenzo, MD has received a total of $3,738 in payments from pharmaceutical and medical device companies, with $813.80 received in 2024. These payments were reported across 74 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,738).
As a Medicare-enrolled provider, Lorenzo has provided services to 1,997 Medicare beneficiaries, totaling 2,477 services with total Medicare billing of $269,752. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Hospitalist
- Location Medley, FL
- Active Since 07/20/2006
- Last Updated 03/21/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1760402820
Products in Payments
- Fycompa (Drug) $488.51
- Fintepla (Drug) $381.88
- Solitaire (Device) $339.09
- Briviact (Drug) $279.87
- EPIDIOLEX (Drug) $271.87
- Nayzilam (Drug) $249.99
- APTIOM (Drug) $191.22
- Vimpat (Drug) $168.21
- INFINITY (Device) $162.50
- GOCOVRI (Drug) $142.01
- VALTOCO (Drug) $138.16
- Ponvory (Drug) $78.12
- BOTOX (Biological) $51.43
- Infinity DBS Pulse Generators (Device) $42.34
- ZEPOSIA (Drug) $24.26
- ULTOMIRIS (Biological) $21.74
- QULIPTA (Drug) $18.97
- INGREZZA (Drug) $18.55
- AFINITOR (Drug) $18.44
- Utibron (Drug) $18.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.